BioStem Technologies, Inc.
BSEM
$4.20
-$0.39-8.50%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 122.97% | -162.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 122.97% | -162.87% | |||
| Cost of Revenue | 75.83% | -19.71% | |||
| Gross Profit | 120.03% | -164.57% | |||
| SG&A Expenses | 111.99% | -174.85% | |||
| Depreciation & Amortization | -5.11% | 12.41% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 119.74% | -167.94% | |||
| Operating Income | 1,184.40% | -97.85% | |||
| Income Before Tax | 725.11% | -96.63% | |||
| Income Tax Expenses | -4.66% | -6.91% | |||
| Earnings from Continuing Operations | 234.85% | -112.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 234.85% | -112.59% | |||
| EBIT | 1,184.40% | -97.85% | |||
| EBITDA | 768.24% | -96.73% | |||
| EPS Basic | 234.32% | -112.57% | |||
| Normalized Basic EPS | 717.91% | -96.61% | |||
| EPS Diluted | 188.76% | -119.88% | |||
| Normalized Diluted EPS | 489.55% | -94.67% | |||
| Average Basic Shares Outstanding | 0.24% | 0.21% | |||
| Average Diluted Shares Outstanding | 39.06% | -36.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||